AU2018232988A1 — Safety syringe and safety dose combination kit
Assigned to Individual · Expires 2018-10-18 · 8y expired
What this patent protects
Methods, apparatuses, and systems are disclosed for reducing Medical Administered Errors (MAE) in the administration of injectable medications to patients by using a syringe device that is designed, labelled, and calibrated to decrease the risk of such errors. The syringe may be …
USPTO Abstract
Methods, apparatuses, and systems are disclosed for reducing Medical Administered Errors (MAE) in the administration of injectable medications to patients by using a syringe device that is designed, labelled, and calibrated to decrease the risk of such errors. The syringe may be designed for a specific medication, and labelled to indicate the name of the medication for which it was designed. The syringe comprises two sets of indicia corresponding to the dosage and the weight or body surface area of a patient, which indicia are calibrated to deliver a specific amount of the medication that is the appropriate dosage for a patient of a particular weight or body surface area, thereby making it unnecessary for the user to perform calculations to determine the correct dosage volume for the particular patient. The syringe may also be calibrated with additional measurement scales that enable the user to verify that the correct dosage.
Drugs covered by this patent
- Decadron (dexamethasone) · Generic (originally Merck)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.